Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2022 Revenue
$59.3B
▲ 21.7% vs FY2021 ($48.7B)
Net Income: $14.5B
Source: 10-K
Merck & Co., Inc. reported $59.3B in revenue for fiscal year 2022. This represents a growth of 21.7% compared to the 2021 figure of $48.7B. In 2023, revenue increased to $60.1B.
Sales jumped roughly 21.7 percent to about 59.3 billion USD, the strongest gain of this period, powered by broad Keytruda volume growth across expanding cancer indications.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $65.0B | — | +2.2% |
| FY2024 | $63.6B | $17.1B | +5.8% |
| FY2023 | $60.1B | $365M | +1.4% |
| FY2022 | $59.3B | $14.5B | +21.7% |
| FY2021 | $48.7B | $13.0B | +1.5% |
| FY2020 | $48.0B | $7.1B | +2.5% |
| FY2019 | $46.8B | $9.8B | +10.7% |
| FY2018 | $42.3B | $6.2B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.